Development of a radiolabeled site-specific single-domain antibody positron emission tomography probe for monitoring PD-L1 expression in cancer
Despite advances in immunotherapy for the treatment of cancers, not all patients can benefit from programmed cell death ligand 1 (PD-L1) immune checkpoint blockade therapy. Anti-PD-L1 therapeutic effects reportedly correlate with the PD-L1 expression level; hence, accurate detection of PD-L1 express...
Saved in:
Main Authors: | Yinfei Chen (Author), Shiyu Zhu (Author), Jiayu Fu (Author), Jianguo Lin (Author), Yan Sun (Author), Gaochao Lv (Author), Minhao Xie (Author), Tao Xu (Author), Ling Qiu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology
by: Christine Rangger, et al.
Published: (2020) -
Synthesis and Biological Evaluation of a Radiolabeled PET (Positron Emission Tomography) Probe for Visualization of In Vivo α-Fucosidase Expression
by: Jonathan Cotton, et al.
Published: (2021) -
Positron Emission Tomography Probes for Imaging Cytotoxic Immune Cells
by: Ala Amgheib, et al.
Published: (2022) -
11C-radiolabeled aptamer for imaging of tumors and metastases using positron emission tomography- computed tomography
by: Anastasia V. Ozerskaya, et al.
Published: (2021) -
Positron emission tomography and positron emission tomography-computerized tomography in pediatric patients
by: Patel Chetan, et al.
Published: (2007)